Invesco Gl.Health Care Innov.Fd.Z AD USD
LU1775952333
Invesco Gl.Health Care Innov.Fd.Z AD USD/ LU1775952333 /
NAV16/08/2024 |
Var.+0.2200 |
Type of yield |
Focus sugli investimenti |
Società d'investimento |
23.8500USD |
+0.93% |
paying dividend |
Equity
Worldwide
|
Invesco Management ▶ |
Investment strategy
The objective of the Fund is to achieve long-term capital growth. The Fund will invest primarily in shares of innovative healthcare companies worldwide. For the purpose of the Fund, healthcare companies include (but are not limited to), pharmaceuticals, biotechnology, healthcare services and medical technology and supplies.
The Fund seeks to invest in companies that have the potential to materially improve the quality of care, access to care or cost of care through their innovative approach to products and services, use of technology, processes and business models, or management. The Fund may use derivatives (complex instruments) to manage the Fund more efficiently, with the aim of reducing risk, reducing costs and/or generating additional capital or income. The Fund is actively managed and is not constrained by its benchmark, MSCI World Health Care Index (Net Total Return), which is used for comparison purposes.
Investment goal
The objective of the Fund is to achieve long-term capital growth. The Fund will invest primarily in shares of innovative healthcare companies worldwide. For the purpose of the Fund, healthcare companies include (but are not limited to), pharmaceuticals, biotechnology, healthcare services and medical technology and supplies.
Dati master
Type of yield: |
paying dividend |
Fondi Categoria: |
Equity |
Region: |
Worldwide |
Settore: |
Sector Health / Pharma |
Benchmark: |
MSCI World Health Care Index (Net Total Return) |
Business year start: |
29/02 |
Ultima distribuzione: |
- |
Banca depositaria: |
The Bank of New York Mellon SA/NV |
Domicilio del fondo: |
Luxembourg |
Permesso di distribuzione: |
Austria, Germany, Switzerland |
Gestore del fondo: |
Justin Livengood |
Volume del fondo: |
305.93 mill.
USD
|
Data di lancio: |
10/09/2018 |
Investment focus: |
- |
Condizioni
Sovrapprezzo emissione: |
5.00% |
Tassa amministrativa massima: |
0.75% |
Investimento minimo: |
1,500.00 USD |
Deposit fees: |
0.01% |
Redemption charge: |
0.00% |
Prospetto semplificato: |
Download (Print version) |
Società d'investimento
Funds company: |
Invesco Management |
Indirizzo: |
An der Welle 5, 60322, Frankfurt am Main |
Paese: |
Germany |
Internet: |
www.de.invesco.com
|
Attività
Stocks |
|
97.44% |
Mutual Funds |
|
2.35% |
Cash |
|
0.21% |
Paesi
United States of America |
|
84.82% |
United Kingdom |
|
4.41% |
Denmark |
|
3.45% |
Ireland |
|
2.09% |
Switzerland |
|
1.58% |
Netherlands |
|
0.93% |
Cash |
|
0.21% |
Australia |
|
0.16% |
Altri |
|
2.35% |
Filiali
Pharma/Biotechnology |
|
44.09% |
Healthcare services |
|
29.94% |
Healthcare appliances |
|
16.70% |
Parma, wholesale |
|
5.69% |
Healthcare |
|
0.81% |
Cash |
|
0.21% |
Gesundheitswesen/ Informationstechnologie |
|
0.20% |
Altri |
|
2.36% |